Office of the Secretary; Amended Notice of Meeting, 45868-45869 [2017-20994]

Download as PDF sradovich on DSK3GMQ082PROD with NOTICES 45868 Federal Register / Vol. 82, No. 189 / Monday, October 2, 2017 / Notices Health Disparities in and Caregiving for Alzheimer’s Disease. Date: October 27, 2017. Time: 8:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: Renaissance Washington DC, Dupont Circle, 1143 New Hampshire Avenue NW., Washington, DC 20037. Contact Person: Gabriel B Fosu, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3108, MSC 7808, Bethesda, MD 20892, (301) 435– 3562, fosug@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; RFA Panel: Molecular Probes. Date: October 27, 2017. Time: 8:00 a.m. to 2:30 p.m. Agenda: To review and evaluate grant applications. Place: Pier 5 Hotel, 711 Eastern Avenue, Baltimore, MD 21202. Contact Person: Mary Custer, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4148, MSC 7850, Bethesda, MD 20892, (301) 435– 1164, custerm@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; PAR Panel: Screenable Disorders: Therapeutics, Tools and Natural History. Date: October 27, 2017. Time: 8:00 a.m. to 3:00 p.m. Agenda: To review and evaluate grant applications. Place: JW Marriott New Orleans, 614 Canal Street, New Orleans, LA 70130. Contact Person: Methode Bacanamwo, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 2200, Bethesda, MD 20892, 301–827–7088, methode.bacanamwo@nih.gov. Name of Committee: Bioengineering Sciences & Technologies Integrated Review Group; Biodata Management and Analysis Study Section. Date: October 27, 2017. Time: 8:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: Renaissance Washington DC, Dupont Circle, 1143 New Hampshire Avenue NW., Washington, DC 20037. Contact Person: Wenchi Liang, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3150, MSC 7770, Bethesda, MD 20892, 301–435– 0681, liangw3@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; PAR Panel: Academic-Industrial Partnerships Research for Cancer Diagnosis and Treatment. Date: October 27, 2017. Time: 8:30 a.m. to 5:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892. Contact Person: Guo Feng Xu, Ph.D., Scientific Review Officer, Center for VerDate Sep<11>2014 19:01 Sep 29, 2017 Jkt 244001 Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5122, MSC 7854, Bethesda, MD 20892, 301–237– 9870, xuguofen@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; PAR–14– 066: Limited Competition: Specific pathogen free macaque colonies. Date: October 27, 2017. Time: 12:00 p.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Barna Dey, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3184, Bethesda, MD 20892, 301–451–2796, bdey@ mail.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Craniofacial Development and Musculoskeletal Tissue Engineering. Date: October 27, 2017. Time: 12:30 p.m. to 3:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Rajiv Kumar, Ph.D., Chief, MOSS IRG, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4216, MSC 7802, Bethesda, MD 20892, 301–435–1212, kumarra@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Topics in Bacterial Pathogenesis. Date: October 30, 2017. Time: 8:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military Road, NW., Washington, DC 20015. Contact Person: Richard G. Kostriken, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3192, MSC 7808, Bethesda, MD 20892, 240–519– 7808, kostrikr@csr.nih.gov. Name of Committee: Oncology 1-Basic Translational Integrated Review Group; Tumor Progression and Metastasis Study Section. Date: October 30–31, 2017. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Ritz-Carlton Hotel, 1700 Tysons Boulevard, McLean, VA 22102. Contact Person: Rolf Jakobi, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6187, MSC 7806, Bethesda, MD 20892, 301–495– 1718, jakobir@mail.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; PAR Panel: Sleep, Health and Disparities. Date: October 30, 2017. Time: 11:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. PO 00000 Frm 00074 Fmt 4703 Sfmt 4703 Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892. Contact Person: Maribeth Champoux, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3170, MSC 7848, Bethesda, MD 20892, 301–594– 3163, champoum@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; PAR15–359: Biomarker Studies for Diagnosing Alzheimer’s Disease and Predicting Progression. Date: October 30, 2017. Time: 11:00 a.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892. Contact Person: Paula Elyse Schauwecker, Ph.D., Scientific Review Officer, National Institutes of Health, Center for Scientific Review, 6701 Rockledge Drive, Room 5211, Bethesda, MD 20892, 301–760–8207, schauweckerpe@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; PAR Panel: Developing and Testing Interventions for Health-Enhancing Physical Activity. Date: October 30, 2017. Time: 12:00 p.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Weijia Ni, Ph.D., Chief/ Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3100, MSC 7808, Bethesda, MD 20892, 301–594– 3292, niw@csr.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: September 27, 2017. David Clary, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2017–21135 Filed 9–29–17; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Office of the Secretary; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the Task Force on Research Specific to Pregnant Women and Lactating Women (PRGLAC) scheduled for November 6–7, 2017, in Conference Room C–D, 6001 Executive Boulevard, National Institutes of Health, Rockville, MD 20852, which was published in the Federal Register on April 18, 2017, 82 FR 18305. E:\FR\FM\02OCN1.SGM 02OCN1 Federal Register / Vol. 82, No. 189 / Monday, October 2, 2017 / Notices The agenda for the meetings is listed below: November 6, 2017—Day 1 8:30 a.m. Welcome and Opening Remarks 8:40 a.m. Introductions 9:15 a.m. Summary and discussion of work products from meeting 1 11:30 a.m. Open Public Presentations 1:15 p.m. Ethical issues surrounding the inclusion of pregnant women and lactating women in clinical research (brief presentations followed by open discussions) 4:50 p.m. Recap of Day 1, Action Items, Charge to Group 5:00 p.m. End of Day 1 sradovich on DSK3GMQ082PROD with NOTICES November 7, 2017—Day 2 8:30 a.m. Recap from Day 1, Outline & Goals of Day 2 8:45 a.m. Panel: Inclusion of pregnant women and lactating women in research (brief presentations followed by open discussions) 10:45 a.m. Panel: Ethical issues of specific clinical research designs (brief presentations followed by open discussions) 1:00 p.m. Panel: Perspectives from industry, research participants, and researchers (brief presentations followed by open discussions) 4:30 p.m. Recap of Day 2, Action Items, Charge to Group 5:00 p.m. End of Day 2—ADJOURN Meeting Public comments are welcome either by filing written comments and/or providing oral comments at the meeting. Oral comments from the public will be scheduled on November 6, 2017 from approximately 11:30 a.m.–12:00 noon. Any member of the public interested in presenting oral comments on November 6, 2017, should submit a letter of intent, a brief description of the organization represented, and the oral presentation to Ms. Lisa Kaeser (Kaeserl@mail.nih.gov) by 5:00 p.m. on Monday October 23, 2017. Written comments to be included at the meeting should also be sent to Lisa Kaeser by 5:00 p.m. on Monday October 23, 2017. The submitted presentations and any written comments will be formatted to be posted on the PRGLAC Web site for the record. Only one representative of an organization may be allowed to present oral comments. Presentations will be limited to three to five minutes per speaker depending on the number of speakers to be accommodated within the allotted time. Speakers will be assigned a time to speak in the order of the date and time when their request to speak is received. Both printed and VerDate Sep<11>2014 19:01 Sep 29, 2017 Jkt 244001 electronic copies are requested for the record. Any changes to the meeting agenda, including tentative times, as well as other relevant additional information about the meeting will be posted on the Web site for the Task Force on Research Specific to Pregnant Women and Lactating Women (PRGLAC) located at: https://www.nichd.nih.gov/about/ advisory/PRGLAC/Pages/index.aspx. Dated: September 26, 2017. Anna Snouffer, Deputy Director, Office of Federal Advisory Committee Policy. [FR Doc. 2017–20994 Filed 9–29–17; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center For Scientific Review; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Synapses, Cytoskeleton and Trafficking. Date: October 18, 2017. Time: 1:00 p.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Geoffrey G Schofield, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4040–A, MSC 7850, Bethesda, MD 20892, 301–435– 1235, geoffreys@csr.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. Name of Committee: Center for Scientific Review Special Emphasis Panel; Developing Computational Power for Biomedical Applications. Date: October 24, 2017. Time: 11:00 a.m. to 5:00 p.m. PO 00000 Frm 00075 Fmt 4703 Sfmt 4703 45869 Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Nitsa Rosenzweig, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4152, MSC 7760, Bethesda, MD 20892, (301) 404– 7419, rosenzweign@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; PAR17–158: Secondary Data Analyses to Explore NIMH Research Domain Criteria (R03). Date: October 25, 2017. Time: 12:00 p.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Boris P Sokolov, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5217A, MSC 7846, Bethesda, MD 20892, 301–408– 9115, bsokolov@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Dynamics of Drug Dependence. Date: October 25, 2017. Time: 12:00 p.m. to 2:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Carole L Jelsema, Ph.D., Chief and Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4176, MSC 7850, Bethesda, MD 20892, (301) 435– 1248, jelsemac@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Fellowships: Cell Biology, Developmental Biology, and Bioengineering. Date: October 26–27, 2017. Time: 8:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: Renaissance Washington DC, Dupont Circle, 1143 New Hampshire Avenue NW., Washington, DC 20037. Contact Person: Raj K Krishnaraju, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6190, Bethesda, MD 20892, 301–435–1047, kkrishna@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Ocular Surface, Cornea, Anterior Segment Glaucoma and Refractive Error. Date: October 26–27, 2017. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Washington Plaza Hotel, 10 Thomas Circle NW., Washington, DC 20005. Contact Person: Kristin Kramer, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5205, E:\FR\FM\02OCN1.SGM 02OCN1

Agencies

[Federal Register Volume 82, Number 189 (Monday, October 2, 2017)]
[Notices]
[Pages 45868-45869]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-20994]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health

Office of the Secretary; Amended Notice of Meeting

Notice is hereby given of a change in the meeting of the Task Force
on Research Specific to Pregnant Women and Lactating Women (PRGLAC)
scheduled for November 6-7, 2017, in Conference Room C-D, 6001
Executive Boulevard, National Institutes of Health, Rockville, MD
20852, which was published in the Federal Register on April 18, 2017,
82 FR 18305.

[[Page 45869]]

The agenda for the meetings is listed below:

November 6, 2017--Day 1

8:30 a.m. Welcome and Opening Remarks
8:40 a.m. Introductions
9:15 a.m. Summary and discussion of work products from meeting 1
11:30 a.m. Open Public Presentations
1:15 p.m. Ethical issues surrounding the inclusion of pregnant women
and lactating women in clinical research (brief presentations followed
by open discussions)
4:50 p.m. Recap of Day 1, Action Items, Charge to Group
5:00 p.m. End of Day 1

November 7, 2017--Day 2

8:30 a.m. Recap from Day 1, Outline & Goals of Day 2
8:45 a.m. Panel: Inclusion of pregnant women and lactating women in
research (brief presentations followed by open discussions)
10:45 a.m. Panel: Ethical issues of specific clinical research designs
(brief presentations followed by open discussions)
1:00 p.m. Panel: Perspectives from industry, research participants, and
researchers (brief presentations followed by open discussions)
4:30 p.m. Recap of Day 2, Action Items, Charge to Group
5:00 p.m. End of Day 2--ADJOURN Meeting

Public comments are welcome either by filing written comments and/
or providing oral comments at the meeting. Oral comments from the
public will be scheduled on November 6, 2017 from approximately 11:30
a.m.-12:00 noon. Any member of the public interested in presenting oral
comments on November 6, 2017, should submit a letter of intent, a brief
description of the organization represented, and the oral presentation
to Ms. Lisa Kaeser (Kaeserl@mail.nih.gov) by 5:00 p.m. on Monday
October 23, 2017. Written comments to be included at the meeting should
also be sent to Lisa Kaeser by 5:00 p.m. on Monday October 23, 2017.
The submitted presentations and any written comments will be formatted
to be posted on the PRGLAC Web site for the record. Only one
representative of an organization may be allowed to present oral
comments. Presentations will be limited to three to five minutes per
speaker depending on the number of speakers to be accommodated within
the allotted time. Speakers will be assigned a time to speak in the
order of the date and time when their request to speak is received.
Both printed and electronic copies are requested for the record.
Any changes to the meeting agenda, including tentative times, as
well as other relevant additional information about the meeting will be
posted on the Web site for the Task Force on Research Specific to
Pregnant Women and Lactating Women (PRGLAC) located at: https://www.nichd.nih.gov/about/advisory/PRGLAC/Pages/index.aspx.

Dated: September 26, 2017.
Anna Snouffer,
Deputy Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-20994 Filed 9-29-17; 8:45 am]
BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.